C4 Therapeutics (CCCC)
(Real Time Quote from BATS)
$6.50 USD
+0.06 (0.93%)
Updated Jul 26, 2024 03:44 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | -0.37 |
EPS Last Quarter | -0.41 |
Last EPS Surprise | 0.00% |
ABR | 1.75 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.56 |
Next Year | -1.82 |
EPS (TTM) | -2.37 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 6.88M | 9.40M | 26.48M | 27.06M |
# of Estimates | 4 | 4 | 4 | 3 |
High Estimate | 14.48M | 17.40M | 37.12M | 30.00M |
Low Estimate | 3.34M | 3.68M | 14.10M | 21.49M |
Year ago Sales | 2.66M | 11.07M | 20.76M | 26.48M |
Year over Year Growth Est. | 158.65% | -15.13% | 27.57% | 2.20% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.37 | -0.37 | -1.56 | -1.82 |
# of Estimates | 5 | 5 | 5 | 5 |
Most Recent Consensus | -0.42 | -0.34 | -1.91 | -3.10 |
High Estimate | -0.18 | -0.27 | -1.01 | -1.35 |
Low Estimate | -0.46 | -0.48 | -1.91 | -3.10 |
Year ago EPS | -0.73 | -0.55 | -2.67 | -1.56 |
Year over Year Growth Est. | 49.32% | 32.73% | 41.57% | -16.92% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.37 | -0.37 | -1.56 | -1.82 |
7 Days Ago | -0.37 | -0.37 | -1.56 | -1.82 |
30 Days Ago | -0.37 | -0.37 | -1.56 | -1.82 |
60 Days Ago | -0.37 | -0.37 | -1.56 | -1.82 |
90 Days Ago | -0.49 | -0.49 | -1.86 | -2.07 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.37 | -0.37 | -1.56 | -1.82 |
Zacks Consensus Estimate | -0.37 | -0.37 | -1.56 | -1.82 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.41 | -0.68 | -0.55 | -0.73 | NA |
Estimate | -0.41 | -0.67 | -0.65 | -0.74 | NA |
Difference | 0.00 | -0.01 | 0.10 | 0.01 | 0.03 |
Surprise | 0.00% | -1.49% | 15.38% | 1.35% | 3.81% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more